IL18 and systemic lupus erythematosus: Caspase-1 is not only responsible for the activation of IL-1β and IL-18, but also triggers pyroptosis, an inflammatory form of programmed cell death that leads to cell lysis and release of cytosolic contents into the extracellular space thus seems well suited for SLE treatment.